Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al' by Costedoat-Chalumeau et al

被引：5
|
作者：
Fanouriakis, Antonis [1 ]
Bertsias, George [2 ,3 ]
Boumpas, Dimitrios T. [1 ,4 ,5 ]
机构：
[1] Attikon Univ Hosp, Dept Internal Med 4, Rheumatol & Clin Immunol, Athens, Greece
[2] Univ Hosp Heraklion, Dept Rheumatol, Clin Immunol & Allergy, Iraklion, Greece
[3] Inst Mol Biol & Biotechnol, Lab Autoimmun Inflammat, Iraklion, Greece
[4] Acad Athens, Lab Autoimmun & Inflammat, Biomed Res Fdn, Athens, Greece
[5] Natl & Kapodestrian Univ Athens, Med Sch, Joint Acad Rheumatol Program, Athens, Greece
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷 / 08期
关键词：
RISK;
D O I：
10.1136/annrheumdis-2019-215615
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Is cigarette smoking a risk factor for systemic lupus erythematosus?: Comment on the article by Costenbader et al
    Sánchez-Guerrero, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (04): : 1340 - 1341
  • [42] Systemic lupus erythematosus and atherosclerosis progression risk: comment on the article by Papazoglou et al.
    Sener, Yusuf Ziya
    Sener, Seher
    ARTHRITIS & RHEUMATOLOGY, 2025,
  • [43] Characterization of flares in patients with systemic lupus erythematosus: comment on the article by Ho et al - Reply
    Petri, M
    Magder, L
    ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 582 - 582
  • [44] Evaluation of renal improvement in juvenile systemic lupus erythematosus: Comment on the articles by Ruperto et al
    Marks, Stephen D.
    Tullus, Kjell
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (06): : 990 - 991
  • [45] The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al
    Major, Gabor A. C.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 1157 - 1158
  • [46] Comment on Predictors of preterm birth in patients with mild systemic lupus erythematosus by Clowse et al
    Rokutanda, Ryo
    Kishimoto, Mitsumasa
    Deshpande, Gautam A.
    Yamaguchi, Kenichi
    Okada, Masato
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (05) : E2 - E2
  • [47] APRIL in systemic lupus erythematosus: essential or dispensable? Comment on the article by Jacob et al Reply
    Jacob, Chaim O.
    Stohl, William
    ARTHRITIS AND RHEUMATISM, 2012, 64 (06): : 2053 - 2054
  • [48] Refining research on systemic lupus erythematosus with key considerations: comment on the article by Xing et al
    Zhou, Qing
    ARTHRITIS & RHEUMATOLOGY, 2025, 77 (01) : 117 - 117
  • [49] Galectin 9: Friend or Foe of Systemic Lupus Erythematosus? Comment on the Article by Zeggar et al
    Xu, Wang-Dong
    Su, Lin-Chong
    Huang, An-Fang
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (05) : 832 - 832
  • [50] EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
    Parodis, Ioannis
    Girard-Guyonvarc'h, Charlotte
    Arnaud, Laurent
    Distler, Oliver
    Domjan, Andrea
    Van den Ende, Cornelia H. M.
    Fligelstone, Kim
    Kocher, Agnes
    Larosa, Maddalena
    Lau, Martin
    Mitropoulos, Alexandros
    Ndosi, Mwidimi
    Poole, Janet L.
    Redmond, Anthony
    Ritschl, Valentin
    Alexanderson, Helene
    Sjoberg, Yvonne
    von Perner, Gunilla
    Uhlig, Till
    Varju, Cecilia
    Vriezekolk, Johanna E.
    Welin, Elisabet
    Westhovens, Rene
    Stamm, Tanja A.
    Bostrom, Carina
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (06) : 720 - 729
12345